Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter.
about
Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious DiseasesAnti-Immune Strategies of Pathogenic FungiThe presence of 3-hydroxy oxylipins in pathogenic microbesCapsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cellsCryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection.Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins.Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity.A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan.Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct.Role for Golgi reassembly and stacking protein (GRASP) in polysaccharide secretion and fungal virulence.The Role of TLR2 in Infection and ImmunityChitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown propertiesVirulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination.Allergen1 regulates polysaccharide structure in Cryptococcus neoformans.Biophysical methods for the study of microbial surfaces.Fungal surface and innate immune recognition of filamentous fungi.Fungal pathogens-a sweet and sour treat for toll-like receptorsFungal glycans and the innate immune recognition.Adjuvants and delivery systems for antifungal vaccines: current state and future developments.What makes Cryptococcus gattii a pathogen?Immune Modulation Capability of Exopolysaccharides Synthesised by Lactic Acid Bacteria and Bifidobacteria.Fungal polysaccharides: biological activity beyond the usual structural properties.Genotypic and Phenotypic Diversity of Cryptococcus gattii VGII Clinical Isolates and Its Impact on Virulence.A Predicted Mannoprotein Participates in Cryptococcus gattii Capsular Structure.Innate Immunity against Cryptococcus, from Recognition to Elimination.Dectin-3 Recognizes Glucuronoxylomannan of Serotype AD and Serotype B to Initiate Host Defense Against Cryptococcosis
P2860
Q26783960-3895212E-30FF-4437-BE15-019A34A625B6Q28071716-E66D6DAE-E497-4A7D-9ACA-F0A1241B1669Q28395036-85DBDB31-09E8-4414-A5DF-C7CA278409D1Q28478860-69496251-0CF3-46F4-B4F8-2F33E81E240EQ34019066-D0E5FDE5-24DC-419E-895D-E67C035D41D3Q34279040-AB10EAF7-E252-43DD-BBDF-A610B32D952AQ34561087-3B09D34E-A643-4B20-8CC0-83F67C2BD710Q34907746-8F0AB216-967C-436E-B0B7-8B90076FA4DEQ34961105-5C4637CC-B33D-43C6-BC44-B7851E528A70Q35072058-F9760064-535E-4B7A-8506-58EB3535C3C5Q35927566-2DD7680C-60CD-49B4-A085-5F3BA632C000Q36244332-05FA6D2B-57E7-45FE-913E-46F6FFB14BFAQ36295449-7EB0B97F-E003-4159-9605-EAD330DB7B43Q36950154-7CD28649-9883-4EF9-AD46-8F21E0127477Q37947585-70D8834A-2396-4475-94AA-4843BA0453C2Q37971025-B07B43BE-5805-42BC-9188-08DDA055190DQ38063202-A675EA81-7577-454C-BA40-67B94A2C9679Q38263533-72E35C92-F85D-4763-809C-A6DBCE0390A5Q38264288-F7B397E9-55F4-4FFE-9AD1-CD75CB331985Q38650835-94ECCF4D-0D9E-4826-A002-650EA9D0FC7CQ38702080-B2ACD9EA-5266-4262-A2B2-A1277257B781Q42025211-A1245033-BA63-413E-81D4-57768F570419Q50250413-D8AFE76E-993E-448C-8C97-489EB899FB50Q55220364-5D04711D-B4AE-479C-B6F8-5D182B1F2FECQ55421879-DAE7AB1A-407B-44B5-B6DB-207F97E17057Q58798947-9795C7D8-0202-4E3C-B0D8-C751A4680429
P2860
Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Immunomodulatory effects of se ...... with polysaccharide diameter.
@en
Immunomodulatory effects of se ...... with polysaccharide diameter.
@nl
type
label
Immunomodulatory effects of se ...... with polysaccharide diameter.
@en
Immunomodulatory effects of se ...... with polysaccharide diameter.
@nl
prefLabel
Immunomodulatory effects of se ...... with polysaccharide diameter.
@en
Immunomodulatory effects of se ...... with polysaccharide diameter.
@nl
P2093
P2860
P356
P1476
Immunomodulatory effects of se ...... with polysaccharide diameter.
@en
P2093
Fernanda L Fonseca
Igor C Almeida
Lilian L Nohara
Marcio L Rodrigues
Radames J B Cordero
Susana Frases
P2860
P304
P356
10.1128/IAI.00111-10
P407
P577
2010-06-14T00:00:00Z